Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ashley Kamimae-Lanning

PhD


Senior Postdoctoral Researcher

My work as a postdoc in the Patel Group is focused on the contribution of endogenous aldehydes to haematopoietic stem cell attrition and carcinogenesis in Fanconi anaemia.


Protection against aldehyde DNA damage is critical for the haematopoietic system

Fanconi anaemia (FA) is an inherited disease in which a pathway coordinating the repair of DNA interstrand crosslinks is inactivated. FA is characterised by developmental anomalies, bone marrow failure (often presenting in childhood), and cancer. Most agents known to cause DNA interstrand crosslinks are chemotherapeutic agents such as cisplatin or compounds found in nature such as psoralen, a photoactivated toxin in certain plants; however, the culprits for DNA damage to cells such as haematopoietic stem cells in FA are unknown and are likely to be produced endogenously. Furthermore, mouse models of FA, of which there are now many, have had a remarkably mild phenotype compared to that seen in humans. Several years ago, our lab discovered that genetic inactivation of key aldehyde detoxifying enzymes in conjunction with knocking out the FA pathway revealed a phenotype in mice similar to that seen in humans with FA, including spontaneous pancytopenia, bone marrow failure, and leukaemia. This compelling result suggests that endogenous and diet-derived aldehydes such as formaldehyde and acetaldehyde, which can attack DNA to form crosslinks, may be a missing piece of the puzzle in determining what drives the phenotypes seen in FA. We call the dual protective effect of metabolic detoxification and DNA repair "two-tier protection."

Although the catabolism of endogenous aldehydes is critical for preserving the proper function, genomic integrity, and longevity of haematopoietic stem and progenitor cells, it is not known whether this protection must be cell-intrinsic or extrinsic, when it is required, and where the aldehydes are being produced or how far they may be able to travel from the site of production. My project's focus is determining whether detoxification is required within haematopoietic cells or whether it can be delegated to other tissues such as liver, and examining when in the development of the blood system it is required.


Endogenous DNA damaging agents in squamous cell carcinoma

Humans with FA have an extraordinary, 500- to 700-fold increased risk of developing head and neck squamous cell carcinoma, compared to the general population. However, what drives the development of these cancers in FA is an open question and given that the FA pathway coordinates the complex process of interstrand crosslink repair, it is plausible that DNA damaging-agents are involved. I am investigating what the consequences are of removing two-tier protection from epithelial tissue, whether endogenous aldehydes drive squamous cell carcinogenesis and if so, which aldehydes are involved.

Murine spleen stained with antibodies against B cells (green) and T cells (red), with nuclei stained with DAPI (blue).
Murine spleen stained with antibodies against B cells (green) and T cells (red), with nuclei stained with DAPI (blue).

Recent publications

More publications